These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35842751)

  • 1. A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation.
    Kitpermkiat R; Thotsiri S; Arpornsujaritkun N; Sangkum P; Chantrathammachart P; Kitpoka P; Thammanichanond D; Virankabutra T; Kantachuvesiri S
    Am J Case Rep; 2022 Jul; 23():e935451. PubMed ID: 35842751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
    Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
    BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
    Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin Inhibitor-Induced Pain Syndrome in ABO-Incompatible Living Kidney Transplantation: A Case Report.
    Ishida S; Kato M; Fujita T; Funahashi Y; Sassa N; Matsukawa Y; Yoshino Y; Yamamoto T; Katsuno T; Maruyama S; Gotoh M
    Transplant Proc; 2017; 49(1):163-166. PubMed ID: 28104127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with ABO-incompatible live donor renal transplantation.
    Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
    J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
    Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
    BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab.
    Tydén G; Kumlien G; Genberg H; Sandberg J; Lundgren T; Fehrman I
    Am J Transplant; 2005 Jan; 5(1):145-8. PubMed ID: 15636623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
    Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure red cell aplasia after major ABO-incompatible bone marrow transplantation: two case reports of treatment with recombinant human erythropoietin.
    Fujisawa S; Maruta A; Sakai R; Taguchi J; Tomita N; Ogawa K; Kodama F; Takahashi K; Shibayama S; Kobayashi S; Ikuta K; Okubo T
    Transpl Int; 1996; 9(5):506-8. PubMed ID: 8875795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S; Hwang E; Park S; Park U; Kim H; Cho W
    Exp Clin Transplant; 2014 Oct; 12(5):401-4. PubMed ID: 25299367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations.
    Tydén G; Donauer J; Wadström J; Kumlien G; Wilpert J; Nilsson T; Genberg H; Pisarski P; Tufveson G
    Transplantation; 2007 May; 83(9):1153-5. PubMed ID: 17496528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic Kidney Transplantation After COVID-19: A Case Report.
    Kijima Y; Shimizu T; Sekido E; Kato S; Kano K; Toguchi M; Horiuchi T; Nozaki T; Omoto K; Inui M; Toma H; Iida S; Takagi T
    Transplant Proc; 2022; 54(6):1551-1553. PubMed ID: 34753590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure Red Cell Aplasia in a Renal Transplant Recipient: Case Report and Review of the Literature.
    Nagib AM; Gheith OA; Zahab MA; Balaha MA; Elserwey NA; Sobhy I; Nair P; Al-Otaibi T
    Exp Clin Transplant; 2022 Mar; 20(Suppl 1):136-139. PubMed ID: 35384824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature.
    Thukral S; Shinde N; Mukherjee K; Ray DS
    Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-filtration plasmapheresis.
    Tanabe K
    Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure red cell aplasia following ABO-incompatible bone marrow transplantation: response to erythropoietin.
    Paltiel O; Cournoyer D; Rybka W
    Transfusion; 1993 May; 33(5):418-21. PubMed ID: 8488547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from pure red cell aplasia caused by anti-erythropoietin antibodies after kidney transplantation.
    Snanoudj R; Beaudreuil S; Arzouk N; Jacq D; Casadevall N; Charpentier B; Durrbach A
    Am J Transplant; 2004 Feb; 4(2):274-7. PubMed ID: 14974951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
    Zhu KE; Li JP; Zhang T; Zhong J; Chen J
    Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.